Literature DB >> 4065296

3[H]-Sulpiride labels mesolimbic non-dopaminergic sites that bind antidepressant drugs.

J G Csernansky, C A Csernansky, L E Hollister.   

Abstract

3[H]-(-)-Sulpiride and 3[H]-spiperone binding was compared in rat amygdala, nucleus accumbens and striatum, using (+/-)-sulpiride to define specific binding. 3[H]-(-)-Sulpiride bound to twice as many sites in amygdala and nucleus accumbens as 3[H]-spiperone. 3[H]-(-)-Sulpiride binding was directed to these additional sites by using 1 microM spiperone to mask dopaminergic binding. The binding of 3[H]-(-)-sulpiride to these sites was high affinity, reversible, Na+-dependent, but not stereospecific. Metoclopramide, tiapride and antidepressant medications, but not other neuroleptics, ADTN, or serotonin displaced 3[H]-(-)-sulpiride binding to these sites. These data suggest that 3[H]-(-)-sulpiride labels mesolimbic sites other than dopamine receptors which may mediate antidepressant effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4065296     DOI: 10.1007/BF01950013

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  24 in total

1.  A study on the localization of [3H]sulpiride binding sites in rat striatal membranes.

Authors:  S B Freedman; A A Mustafa; J A Poat; K A Senior; C P Wait; G N Woodruff
Journal:  Neuropharmacology       Date:  1981-12       Impact factor: 5.250

2.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

3.  Binding of [3H]sulpiride to purified rat striatal synaptic membranes.

Authors:  G N Woodruff; S B Freedman
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

4.  Effects of sulpiride isomers on the control of anterior pituitary secretion in normal man.

Authors:  L F Agnati; P Cortelli; E De Camillis; F Benfenati; F Orlandi; P Fresia
Journal:  Neurosci Lett       Date:  1979-12       Impact factor: 3.046

5.  Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.

Authors:  N R Zahniser; M L Dubocovich
Journal:  J Pharmacol Exp Ther       Date:  1983-12       Impact factor: 4.030

6.  A randomized double blind group comparative study of sulpiride and amitriptyline in affective disorder.

Authors:  H M Standish-Barry; N Bouras; P K Bridges; J P Watson
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Characterization of stereospecific binding of 3H-(-) sulpiride, a selective antagonist at dopamine-D2 receptors, in rat CNS.

Authors:  M Memo; S Govoni; E Carboni; M Trabucchi; P F Spano
Journal:  Pharmacol Res Commun       Date:  1983-02

8.  Comparison of alprazolam, imipramine, and placebo in the treatment of depression.

Authors:  J P Feighner; G C Aden; L F Fabre; K Rickels; W T Smith
Journal:  JAMA       Date:  1983-06-10       Impact factor: 56.272

9.  Blockade of dopamine receptors in the renal vasculature by isomers of flupenthixol and sulpiride.

Authors:  M Schmidt; J L Imbs; E M Giesen; J Schwartz
Journal:  J Cardiovasc Pharmacol       Date:  1983 Jan-Feb       Impact factor: 3.105

10.  Possible mixed agonist--antagonist activity of D-sulpiride at dopamine receptor level in man.

Authors:  F Benfenati; P Bernardi; P Cortelli; M Capelli; C Adani; L Calzà; L F Agnati
Journal:  Neurosci Lett       Date:  1981-11-04       Impact factor: 3.046

View more
  7 in total

1.  Infralimbic D2 receptors are necessary for fear extinction and extinction-related tone responses.

Authors:  Devin Mueller; Christian Bravo-Rivera; Gregory J Quirk
Journal:  Biol Psychiatry       Date:  2010-12-01       Impact factor: 13.382

2.  Chronic administration of l-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of "depression-like" behavior.

Authors:  A V Vergoni; A Forgione; A Bertolini
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

3.  Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.

Authors:  E S Prosser; R Pruthi; J G Csernansky
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Ramelteon Improves Post-traumatic Stress Disorder-Like Behaviors Exhibited by Fatty Acid-Binding Protein 3 Null Mice.

Authors:  Yasushi Yabuki; Ibuki Takahata; Kazuya Matsuo; Yuji Owada; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

5.  The nucleus accumbens and antidepressants: modulation of ergometrine-induced hyperactivity by typical and atypical antidepressants and neuroleptics in rats.

Authors:  A R Cools
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 6.  Tiapride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation.

Authors:  J W Steele; D Faulds; E M Sorkin
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

Review 7.  Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome.

Authors:  D H Peters; D Faulds
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.